Monday, March 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Antimicrobial Resistance

New, Unusually Large Virus Kills Anthrax Agent

by Global Biodefense Staff
January 30, 2014
Zebra Anthrax Bacteriophage
Zebras graze in Etosha National Park, Namibia. The new bacteriophage virus called Tsamsa, isolated from zebra carcasses in the park, kills the anthrax bacterium. Credit: Holly Ganz, UC Davis.

From a zebra carcass on the plains of Namibia in Southern Africa, an international team of researchers has discovered a new, unusually large virus (or bacteriophage) that infects the bacterium that causes anthrax. The novel bacteriophage could eventually open up new ways to detect, treat or decontaminate the anthrax bacillus and its relatives that cause food poisoning. The work is published Jan. 27 in the journal PLOS One.

The virus was isolated from samples collected from carcasses of zebras that died of anthrax in Etosha National Park, Namibia. The anthrax bacterium, Bacillus anthracis, forms spores that survive in soil for long periods. Zebras are infected when they pick up the spores while grazing; the bacteria multiply and when the animal dies, they form spores that return to the soil as the carcass decomposes.

While anthrax is caused by a bacterium that invades and kills its animal host, bacteriophages, literally “bacteria eaters” are viruses that invade and kill bacterial hosts.

The first thing the team noticed was that the virus was a voracious predator of the anthrax bacterium, said Holly Ganz, a research scientist at the University of California, Davis Genome Center and first author on the paper.

They also noticed that the new virus, named Bacillus phage Tsamsa, is unusually large, with a giant head, a long tail and a large genome, placing it among the largest known bacteriophages.

Tsamsa infects not only B. anthracis but also some closely related bacteria, including strains of Bacillus cereus, which can cause food poisoning. Sequencing the genome allowed researchers to identify the gene for lysin, an enzyme that the virus uses to kill bacterial cells, that has potential use as an antibiotic or disinfecting agent.

Bacteriophages are often highly specific to a particular strain of bacteria, and when they were first discovered in the early 20th century there was strong interest in them as antimicrobial agents. But the discovery of penicillin and other antibiotics eclipsed phage treatments in the West, although research continued in the Soviet Union.

“With growing concerns about antibiotic resistance and superbugs, people are coming back to look at phages,” said Ganz said.

One advantage of bacteriophages is that because they tend to be very specific, they can potentially target only “bad” bacteria while leaving beneficial bacteria unharmed.

Ganz began the work as a postdoctoral scientist on a team led by Wayne Getz, Professor of Environmental Science, Policy and Management at UC Berkeley and at the University of KwaZulu-Natal, South Africa. Sequencing of the phage genome was conducted at UC Davis after Ganz joined the laboratory of Professor Jonathan Eisen.

Ganz said that she hoped the publication of the phage’s sequence information would enable other researchers to investigate further and potentially develop applications for the phage and its proteins.

“You might use it to detect the anthrax Bacillus or B. cereus; use it as an alternative to antibiotics or as part of a decontaminant,” she said.

Read the paper at PLOS One: Novel Giant Siphovirus from Bacillus anthracis Features Unusual Genome Characteristics.

Tags: AnthraxAntimicrobialsBioterrorism

Related Posts

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
How Are Bivalent COVID Vaccines Stacking Up Against Omicron?
Infectious Diseases

How Are Bivalent COVID Vaccines Stacking Up Against Omicron?

January 12, 2023
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC